07th Masterclass In Lung Cancer - Day 3 - 21st July 2024
CRSF 7th Masterclass in Lung Cancer | Role of Radiation in LD SCLC by Dr. Dodul Mondal | Day 3
CRSF 7th Masterclass in Lung Cancer | Concurrent Chemotherapy for LD SCLC by Dr. Amit Kumar | Day 3
CRSF 7th Masterclass in Lung Cancer | Regimen Selection for Poor PS & SVCO by Dr. Tarachand Gupta
CRSF 7th Masterclass | Revolutionizing ES SCLC Care: Panel Discussion by Dr. Akhil Kapoor & Experts
CRSF 7th Masterclass | Second-Line Treatment Selection for ED SCLC by Dr. Akansha Choudhary
CRSF 7th Masterclass | Interpreting KRAS Mutation in Lung Cancer by Dr. Rushabh Kothari | Day 3
CRSF 7th Masterclass | 1st Line Therapy Selection for KRAS in Lung Cancer by Dr. Akhil Kapoor
CRSF 7th Masterclass | Resistance to KRAS TKI & Post-Resistance Therapy by Dr. Soumya Surath Panda
CRSF 7th Masterclass | Hidden EGFR Threats & Role of Amivantamab by Dr. Anshul Gupta | Day 3
CRSF 7th Masterclass | Panel on EGFR & KRAS Therapies: Dr. Akhil Kapoor & Experts Discuss
CRSF 7th Masterclass | Exon 20 Insertion Interpretation in Lung Cancer by Dr. Amit Verma | Day 3
CRSF 7th Masterclass | BRAF Mutation Testing: Technologies & Interpretation by Dr. Aparna Dhar
CRSF 7th Masterclass | 1st Line Targeted Therapy for BRAF NSCLC by Dr. Mohit Sharma | Day 3
CRSF 7th Masterclass | CERITINIB: Frontline Treatment for ALK+ NSCLC by Dr. Rohit Pai
CRSF 7th Masterclass | CAR-T Cell Therapy in Lung Cancer by Dr. Vijay Patil | Day 3
CRSF 7th Masterclass | RET Mutation Interpretation in Lung Cancer by Dr. Trupti Pai | Day 3
CRSF 7th Masterclass | First-Line RET Targeted Therapy in Lung Cancer by Dr. Chakor Vora
CRSF 7th Masterclass | Resistance to RET TKI & Post-Resistance Therapy by Dr. Vibhor Sharma
CRSF 7th Masterclass | First-Line Therapy for NTRK+ Lung Cancer by Dr. Bhavesh Poladia
CRSF 7th Masterclass | Resistance to NTRK TKIs & Post-Resistance Therapy by Dr. Kripa Bajaj
CRSF 7th Masterclass | MET Amplification & Exon 14 Skip Mutation in NSCLC by Dr. Anuradha Chougule
CRSF 7th Masterclass | 1st Line Therapy for MET Amplification & Exon 14 Mutation by Dr. Anmol Patel
CRSF 7th Masterclass | MET Amplification & Exon 14 Skip Mutation in NSCLC by Dr. Sunil Pasricha
CRSF 7th Masterclass | 1st Line Therapy for ROS1 Rearrangement in NSCLC by Dr. Sandeep Jasuja
CRSF 7th Masterclass | Resistance to ROS1 Therapy & Post-Resistance Strategies by Dr. Abhishek Anand
CRSF 7th Masterclass | Closing Remarks & Vote of Thanks by Dr. Ashay Karpe